So transgender teens are now buying hormone-altering drugs online. The NHS injects children wanting to swap their gender with the puberty blocker Gonapeptyl, costing taxpayers £82 per dose. One of its many side effects, apart from causing depression, vaginal bleeding, vomiting, hair loss, and emotional instability, is that it desensitises the pituitary gland. You can buy it online for £110.50.
Lucy Griffin, consultant psychiatrist at Bristol Royal Infirmary, has warned that doctors know very little about the long-term effects of medicines designed to delay the onset of puberty and that there is a risk of osteoporosis, permanent infertility or impaired sexual function.
Not surprisingly, pharmaceutical companies in the US are contributing millions of dollars to LGBT causes. In the two-year period of 2015-2016, institutional funding for LGBTI issues globally totalled approximately $524million, a $100million increase from 2013-14. Funding specifically focused on transgender communities totalled $26.1 million.
. . . Big Pharma such as Janssen Therapeutics, the health foundation of a Johnson and Johnson founder, Viiv, Pfizer, Abbott Laboratories, Bristol-Myers Squibb Company, and Boehringer Ingelheim Pharmaceuticals, are pouring big money into the transgender project.